$IDRA Headlines Charting a bullish early-2014 outlook

New Post Public Reply Private Reply Replies (0) Message Board

Jan 31, 2014 at 1:22 PM

$IDRA Headlines

Charting a bullish early-2014 outlook 12:05 p.m. Dec. 31, 2013 - Michael Ashbaugh
Charting a bullish early-2014 outlook 11:39 a.m. Dec. 31, 2013 - Michael Ashbaugh
S&P, Nasdaq rally from major support 11:09 a.m. Dec. 16, 2013 - Michael Ashbaugh
Pfizer, Affymetrix weigh on drug stocks 2:04 p.m. July 7, 2011 - Val Brickates Kennedy
Idera tumbles 14% on drug setback 1:52 p.m. July 7, 2011 - Val Brickates Kennedy
Tuesday's biggest gaining and declining stocks 4:37 p.m. Jan. 19, 2010 - MarketWatch
Incyte, Idera move on Novartis deals 2:02 p.m. Nov. 25, 2009 - Val Brickates Kennedy
Novartis terminates pact with Idera 8:28 a.m. Nov. 25, 2009 - Val Brickates Kennedy
Wednesday's biggest gaining and declining stocks 4:29 p.m. Dec. 26, 2007 - MarketWatch
Idera Pharmaceuticals' president, Karr, resigns 9:08 a.m. Dec. 26, 2007 - Robert Daniel
Idera Pharma President Karr resigns, stays on board 9:03 a.m. Dec. 26, 2007 - Robert Daniel
Idera signs agonist licensing, collaboration with Merck KGaA 7:10 a.m. Dec. 19, 2007 - Sarah Turner
Idera to get up to $381 mln in milestones 7:03 a.m. Dec. 19, 2007 - Steve Goldstein
Idera, Merck KGaA agree collaboration deal 7:02 a.m. Dec. 19, 2007 - Steve Goldstein
Wednesday's biggest stock gainers and decliners 6:03 p.m. Feb. 28, 2007 - Michael Baron
Idera Pharma started at buy at Merriman Curhan Ford 8:54 a.m. Feb. 7, 2007 - Tomi Kilgore
Drug stocks slip; Nuvelo, Neopharm shares plunge on trial results 4:37 p.m. Dec. 11, 2006 - Carolyn Pritchard

Idera Pharmaceuticals: Set To Ride A 200% Gain In 2014 9:38 a.m. Today - Seeking Alpha
First Week Of IDRA March 22nd Options Trading 10:54 a.m. Jan. 23, 2014 - TheStreet.com
Perilous Reversal Watch: Idera Pharmaceuticals (IDRA) 9:47 a.m. Jan. 23, 2014 - TheStreet.com
Good Action Under the Surface 4:45 p.m. Jan. 22, 2014 - RealMoney.com
Price Action Tells the Story 2:05 p.m. Jan. 22, 2014 - RealMoney.com
Tricky and Misleading Action 10:45 a.m. Jan. 22, 2014 - RealMoney.com
Today's Dead Cat Bounce Stock Is Idera Pharmaceuticals (IDRA) 9:48 a.m. Jan. 9, 2014 - TheStreet.com
Perilous Reversal Watch: Idera Pharmaceuticals (IDRA) 3:04 p.m. Jan. 8, 2014 - TheStreet.com
Idera Pharmaceuticals Presents a Promising Opportunity 2:23 p.m. Dec. 26, 2013 - Wall St. Cheat Sheet
Friday’s Biggest Stock Losers: INSY OPK, and More 7:52 a.m. Dec. 13, 2013 - InvestorPlace.com
9 Biotechnology Stocks to Buy Now 6:00 a.m. Dec. 11, 2013 - InvestorPlace.com
10-Q: IDERA PHARMACEUTICALS, INC. 7:02 a.m. Nov. 14, 2013 - Edgar Online - (EDG = 10Q, 10K)
Biotech-Focused Baker Bros. Accumulates These 3 Stocks 8:55 a.m. Oct. 1, 2013 - Seeking Alpha
Idera Phase 2 Data Provides For Exciting Q4 2013 And Q1 2014 8:02 a.m. Sept. 25, 2013 - Seeking Alpha
Analysts: Blackstone Mortgage Gaining Traction and 3 Other Research Notes to Browse 1:37 p.m. Aug. 29, 2013 - Wall St. Cheat Sheet
Idera Enters Agreement with NCI to Evaluate Use of TLR Antagonists for Treatment of Genetically Defined Lymphomas 6:39 a.m. Aug. 29, 2013 - benzinga.com
Idera Announces Issuance of US Patent Covering IMO-8400, Lead Candidate in Phase 2 Trial 6:05 a.m. July 18, 2013 - benzinga.com
Idera Pharma to Issue Positive Phase I Trial Results on TLR Antagonist IMO-8400 5:31 a.m. June 21, 2013 - benzinga.com
Idera Pharmaceuticals Announces Initiation of a Phase 2 Trial of IMO-8400 in Patients with Moderate to Severe Plaque Psoriasis 6:07 a.m. June 5, 2013 - benzinga.com
10-Q: IDERA PHARMACEUTICALS, INC. 6:49 a.m. May 15, 2013 - Edgar Online - (EDG = 10Q, 10K)

Idera Announces Publication of New Data Demonstrating Impact of Inhibiting TLRs 7, 8, and 9 in a Preclinical Model of Autoimmune Disease 8:01 a.m. Jan. 22, 2014 - BusinessWire - BZX
Healthcare Companies Report Conference Presentation Schedule, Stock Price Updates, and Clinical Study Results - Research Report on Medivation, Envision Healthcare, Fonar, Idera Pharma, and Neurocrine 8:00 a.m. Jan. 9, 2014 - PR Newswire
Idera Expands Leadership Team and Strengthens Clinical Development Expertise in Oncology and Orphan Diseases 8:00 a.m. Jan. 9, 2014 - BusinessWire
Relocation Plans, Patient Enrollment, Management Appointments, and Price Movements - Research Report on HCA Holdings, Opko Health, Santarus, Coronado, and Idera 8:00 a.m. Dec. 31, 2013 - PR Newswire
Senior Appointments, Stock Splits, New Guidelines, Positive Results, and Clinical Trial Updates - Research Report on Receptos, MEDNAX, CombiMatrix, Anacor, and Idera 8:00 a.m. Dec. 10, 2013 - PR Newswire
Idera Pharmaceuticals Opens Enrollment for Phase 1/2 Clinical Trial of IMO-8400 in Waldenstrom's Macroglobulinemia 7:30 a.m. Dec. 4, 2013 - BusinessWire
Idera Pharmaceuticals to Present at the 25th Annual Piper Jaffray Healthcare Conference 4:02 p.m. Nov. 25, 2013 - BusinessWire
Idera Pharmaceuticals Reports Third Quarter 2013 Financial Results and Provides Corporate Update 7:45 a.m. Nov. 14, 2013 - BusinessWire
Idera Pharmaceuticals to Host Conference Call to Report Third Quarter 2013 Financial Results on Thursday, November 14, 2013 4:10 p.m. Nov. 7, 2013 - BusinessWire
Idera Pharmaceuticals Announces Closing of Public Offering of Common Stock and Pre-Funded Warrants 3:14 p.m. Sept. 30, 2013 - BusinessWire
Idera Pharmaceuticals Announces Pricing of Public Offering of Common Stock and Pre-Funded Warrants 8:09 a.m. Sept. 25, 2013 - BusinessWire
Idera Pharmaceuticals Announces Public Offering of Common Stock and Pre-Funded Warrants 3:01 p.m. Sept. 24, 2013 - BusinessWire
Five Star Equities Issues New Research Reports on EZCH, IDRA, PSTI and UNFI 8:01 a.m. Sept. 13, 2013 - ACCESSWIRE
Idera to Provide Update on Programs at Stifel Nicolaus Healthcare Conference 11:00 a.m. Sept. 12, 2013 - BusinessWire
Idera to Present at the Stifel Nicolaus 2013 Healthcare Conference 8:25 a.m. Sept. 10, 2013 - BusinessWire
Idera Pharmaceuticals Enters into Agreement with NCI to Evaluate Use of TLR Antagonists for the Treatment of Genetically Defined Lymphomas 7:30 a.m. Aug. 29, 2013 - BusinessWire
Idera Pharmaceuticals Reports Second Quarter 2013 Financial Results and Corporate Highlights 7:00 a.m. Aug. 15, 2013 - BusinessWire
Idera Announces Issuance of US Patent Covering IMO-8400, Lead Candidate in Phase 2 Trial 7:00 a.m. July 18, 2013 - BusinessWire
Idera Pharmaceuticals Appoints James Geraghty as Chairman of the Board of Directors 8:00 a.m. July 10, 2013 - BusinessWire
Idera Pharmaceuticals Announces Results of Phase 1 Clinical Trial of IMO-8400, Toll-like Receptor Antagonist Drug Candidate for Autoimmune and Inflammatory Diseases 7:00 a.m. July 1, 2013 - BusinessWire

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Lincoln Education Faces Securities Fraud Lawsuit Headwinds

You wake up one morning, check your portfolio, and there it is—a 24.93% nosedive from Lincoln Educational Services Corp. (NASDAQ:LINC). That ain't a typo, my friend. That's reality smacking you right in the face. Now, what's cooking here? Why did this education stock tank, and what should you, as an investor, be doing about it? Well, pull up a chair, and let's dissect...

Deep Principle's Hydrogen-1.0: A Leap in AI-Driven Chemistry

Leaving Old Lab Notebooks in the Dust Deep Principle just shook up the science lab with their latest brainchild, Hydrogen-1.0. We're talking about an AI-driven marvel designed to tackle chemistry and materials research like no traditional lab rat ever could. On November 4, they rolled out this bad boy—an open-weight model fine-tuned to turn vague scientific hunches into...

APEC CEO Summit Marries Innovation and Global Ties

Shenzhen: The Heartbeat of Future Business Shenzhen isn't just a city on the map. It's an exploding innovation powerhouse, a place where global business leaders will rub shoulders this November for the 2026 APEC CEO Summit. This ain't your average conference, my friends. CCPIT (China's national trade pushers) are hosting it from November 17 to 18, promising a powerhouse...

Cheche Group Proposes New Share Class with Heavy Voting Power

Cheche Group: A Real Shake-Up for Investors November 5, 2026—here we have a little whirlwind from Beijing as Cheche Group Inc., a significant insurer dealmaker in China's auto tech world, has stirred up an extraordinary general meeting for November 25th. This isn't just another corporate shindig; we're talking about throwing a new class of shares into the mix—each one...

Real Estate Sage: Tad Barber's Tips on Selling Your Home

Kicking Off the 2027 Home Selling Game Plan Let me tell you, the real estate world isn't for the faint-hearted. It’s a realm where a solid game plan makes a world of difference, especially when you're thinking about selling your home in 2027. In Aiken, South Carolina, it seems the local know-it-all Tad Barber has teamed up with HelloNation to throw down some insight on...

Signature Aviation, JA Partner to Inspire Young Aviators

Signature Aviation and JA Worldwide Join Forces Signature Aviation and Junior Achievement (JA) Worldwide are getting crafty and forming a new partnership, aimed at pulling the curtain back on the aviation industry for high school students. It's all about workforce readiness and carving out career paths, and this is the kind of hands-on stuff that's got legs. It kicks off...

Rice Sets Course in Houston’s Thriving Innovation Hub

Houston's Innovation Scene Expands The ground's barely settled and already Rice University is shaking up the scene in Houston’s Ion District with the Arc. At nearly 200,000 square feet, this powerhouse is set to bridge the gap between research, industry, and entrepreneurs, pushing ideas from discovery to reality. A Groundbreaking Investment For anyone with half an idea...

Mondego Bio Charges Ahead with Cancer Therapy Trials

Cracking Cancer's Code: Mondego's Bold Move Big news from Portugal today—a quiet town called Cantanhede is now the epicenter of a potential game-changer in cancer therapy. Mondego Bio, with its small-molecule innovator MB?388, is diving headfirst into a Phase 1 clinical study. If you're scratching your head about the significance, let me spell it out: this is an attempt...

Nuvoton and Qt Amps Up Graphic Interfaces

By Thomas Cooper Updated Nov 5, 2026 Category News Views 116

Introducing Gerda (TM) IC: Game-Changer Your everyday products just got a whole lot smarter, as Nuvoton Technology Corporation and Qt Group have joined hands to bring a revolutionary graphic interface system—behold, the Gerda (TM) IC. This announcement is just the tip of the iceberg for product developers working within tight budgets. Imagine creating premium graphics...

Global Leaders Unite to Tackle Major World Challenges

Gathering Minds in Washington: A Summit to Remember Let me tell you straight – when over a hundred heavyweights from government, finance, and tech get in the same room, you bet people start paying attention. We’re talking about the 2026 WICE Global Impact Summit that went down at The Penthouse in The Washington Post Building. The movers and shakers weren't there to...